SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-19-000441
Filing Date
2019-05-03
Accepted
2019-05-03 17:00:24
Documents
6
Period of Report
2019-05-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e618411_8k-adma.htm 8-K 27993
2 e618411_ex4-1.htm EX-4.1 6194
3 e618411_ex4-2.htm EX-4.2 90612
4 e618411_ex10-1.htm EX-10.1 57869
5 e618411_ex99-1.htm EX-99.1 17839
6 GRAPHIC logo.jpg GRAPHIC 11097
  Complete submission text file 0001193805-19-000441.txt   217380
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 19797041
SIC: 2836 Biological Products, (No Diagnostic Substances)